EP2364142
Samsetningar af 5-HT2A serótónínviðtakastilli sem eru nytsamlegar við meðhöndlun á röskunum sem tengjast honum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
27.10.2009EP published:
17.1.2018EP application number:
09752512.5
EP translation filed:
16.4.2018Grant published:
15.5.2018EPO information:
European Patent Register
Max expiry date:
26.10.2029Expiry date:
26.10.2020
Title:
COMPOSITIONS OF A 5-HT2A SEROTONIN RECEPTOR MODULATOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
Timeline
Today
27.10.2009EP application
17.1.2018EP Publication
16.4.2018Translation submitted
15.5.2018Registration published
26.10.2020Expires
Owner
Name:
Arena Pharmaceuticals, Inc.Address:
6154 Nancy Ridge Drive, 92121, San Diego, CA, US
Inventor
Name:
SELVEY, Lee, AlaniAddress:
PowayCalifornia, US
Name:
CARLOS, Marlon V.Address:
Chula VistaCalifornia, US
Name:
MAFFUID, PaulAddress:
CarlsbadCalifornia, US
Name:
SHAN, YunAddress:
San DiegoCalifornia, US
Name:
HART, Ryan, M.Address:
San Francisco, CA, US
Name:
BETTS, William, L., IIIAddress:
San Diego, CA, US
Name:
SHAO, Zezhi, JesseAddress:
San Diego, CA, US
Name:
GIVEN, Deam, Windate, IIIAddress:
San Diego, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
197542 PDate:
28.10.2008Country:
US
Classification
Categories:
A61K 9/20, A61K 31/415
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 2.10.2018
Expires: 26.10.2019
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 1.10.2019
Expires: 26.10.2020
Payer: Sigurjónsson & Thor ehf.